Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K/AKT pathway
Yasushi Iida(Jikei University School of Medicine), Aikou Okamoto(Jikei University School of Medicine)
Cited by 0
Related Papers
Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma
|International Journal of Oncology|2012|68
Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway
|Gynecologic Oncology|2022|15